Skip to main content
. 2017 Nov;92(5):1261–1271. doi: 10.1016/j.kint.2017.04.028

Table 1.

Clinical features at presentation

Clinical feature Number of patients
Age, yr (N = 17) Median: 8 yr; range: 1–15 yr
Sex (N = 17) Male: n = 11 Female: n = 6
Prodrome (N = 16) Abdominal pain n = 9b
Vomiting n = 9b
Diarrhea n = 8b
Fever n = 4
Other a
Clinical features (N = 16) Hematuria n = 12
Proteinuria n = 13
Oligoanuria n = 10
Hypertension n = 9
Edema n = 3
Triggering event (N = 17) Infection n = 7
None identified n = 10
Extrarenal manifestations (N = 16) None n = 8
Seizures n = 3
Hepatitis n = 2
Epistaxis n = 2
Pancreatitis n = 1
Altered consciousness n = 1
Laboratory features at presentation Mean (range)
Hemoglobin, g/dl (N = 17) 6.6 (4–9.1)
Platelet count, ×109 (N = 17) 52 (9–134)
Creatinine, μmol/l (N = 17) 331 (61–1131)
Lactate dehydrogenase, U/L (N = 16) 4460 (887–17,584)
Antinuclear antibodies (N = 12) 1/12 positive 1:40
a

Other prodromal symptoms reported in ≤2 patients: headache, malaise, cough, visible hematuria, petechiae, and flulike illness.

b

Twelve patients had at least 1 gastrointestinal symptom (abdominal pain, vomiting, diarrhea).